The Multiple Myeloma Channel is supported with funding from BMS (Gold) and Legend Biotech (Bronze).
VJHemOnc is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.
ESH MM 2018 | Early detection and intervention in myeloma: a critical point
Jesús San Miguel
• 5 Oct 2018
While our treatments for multiple myeloma (MM) are improving all the time, the best time to eradicate disease is early on. Here, Jesús San Miguel, MD, PhD, of the University of Navarra, Pamplona, Spain, discusses the importance of early intervention from the European School of Haematology (ESH) International Conference on MM 2018, held in Mandelieu, France.
